000			01985 a2200541 4500
005			20250515222956.0
264		0	_c20100813
008			201008s 0 0 eng d
022			_a1476-5586
024	7		_a10.1593/neo.10110 _2doi
040			_aNLM _beng _cNLM
100	1		_aLee, Pei-Chih
245	0	0	_aCombination of bifunctional alkylating agent and arsenic trioxide synergistically suppresses the growth of drug-resistant tumor cells. _h[electronic resource]
260			_bNeoplasia (New York, N.Y.) _cMay 2010
300			_a376-87 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents, Alkylating _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aApoptosis
650	0	4	_aArsenic Trioxide
650	0	4	_aArsenicals _xadministration & dosage
650	0	4	_aBlotting, Western
650	0	4	_aCarbamates _xadministration & dosage
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCell Separation
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aDrug Synergism
650	0	4	_aFlow Cytometry
650	0	4	_aFluorescent Antibody Technique
650	0	4	_aHeterocyclic Compounds, 3-Ring _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aIn Situ Nick-End Labeling
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aNeoplasms, Experimental _xdrug therapy
650	0	4	_aOxides _xadministration & dosage
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aKakadiya, Rajesh
700	1		_aSu, Tsann-Long
700	1		_aLee, Te-Chang
773	0		_tNeoplasia (New York, N.Y.) _gvol. 12 _gno. 5 _gp. 376-87
856	4	0	_uhttps://doi.org/10.1593/neo.10110 _zAvailable from publisher's website
999			_c19809770 _d19809770